UBS raised the firm’s price target on Ovintiv to $65 from $64 and keeps a Buy rating on the shares. The firm continues to see a positive outlook for Ovintiv heading into 2024, adding that the company is one of the key beneficiaries of the higher crude oil price environment post the April 2023 acquisition.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on OVV: